ANGPTL2 and polycystic ovary syndrome: Based on the above theory, metformin treatment decreased the expression of ANGPTL2 mRNA when compared with the PCOS model group (P < 0.05), indicating that metformin might improve IR by reducing the expression of ANGPTL2.